Abstract
Limitation of conventional human Ether-a-go-go Related Gene (hERG) assay and QT prolongation testing for accurate prediction of Torsades de Pointes (TdP) by compounds showed us the necessity of a new approach to evaluate global cardiac safety. As one of the advanced applications of an on-chip cellomics system, on-chip cardiomyocyte cell network-based re-entry model assay has the potential to measure the TdP probability as a pre-clinical test for cardiac safety. This system also can estimate the heart pressure, Na, K, and Ca ion channel conditions using a single cell-based optical/electrical measurement system. In this presentation, we present the system setup and then its possible application for drug discovery and toxicology.
Original language | English |
---|---|
Pages (from-to) | 545-557 |
Number of pages | 13 |
Journal | Yakugaku Zasshi |
Volume | 130 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2010 Apr |
Externally published | Yes |
Keywords
- On-chip cellomics
- On-chip re-entry model
- Torsades de Pointes (TdP)
ASJC Scopus subject areas
- Pharmacology
- Pharmaceutical Science